Background Cost-effectiveness analyses have been conducted for many interventions for
HIV/AIDS, malaria, syphilis, and tuberculosis, but they have not been conducted for all …

Background Sexually active older adults are often more susceptible to HIV and other
sexually transmitted infections (STIs) due to various health conditions (especially a …

Objective The existing prognostic models for mortality risk in people living with HIV (PLWH)
may not be applicable for older PLWH because the risk factors were confined to biomarkers …

Despite attempts to control the spread of human immunodeficiency virus (HIV) through the
use of anti‐HIV medications, the absence of an effective vaccine continues to present a …

Background Human immunodeficiency virus (HIV) affects nearly 40 million people globally,
with roughly 80% of all people living with HIV receiving antiretroviral therapy. Antiretroviral …

Although the burden of the human immunodeficiency virus (HIV) in the Asia‐Pacific region is
increasingly severe, comprehensive evidence of the burden of HIV is scarce. We aimed to …

Acquired immunodeficiency syndrome (AIDS) is a potentially fatal condition affecting the
human immune system, which is attributed to the human immunodeficiency virus (HIV). The …

Abstract Although several Latin American countries have 70% antenatal care coverage, the
proportion of human immunodeficiency virus (HIV) testing of Peruvian pregnant women and …

Lack of access to resources is a “fundamental cause” of poor HIV outcomes across the care
cascade globally and may have the greatest impact on groups with co-existing marginalized …

Abstract Background Antiretroviral Therapy (ART) is pivotal in extending the lives of people
living with HIV (PLWH) and minimizing transmission. Rapid ART initiation, defined as …